Brief: Diagonal Bio Q2 Operating Loss At SEK 4.34 Mln
23/08/2022 07:10
Aug 23 (Reuters) - Diagonal Bio AB 9F1.F :
* Q2 REVENUE AMOUNTED TO SEK 995,000 (SEK 2,469,000)
* Q2 OPERATING LOSS AMOUNTED TO SEK 4.34 MILLION VERSUS LOSS
SEK
3.07 MILLION YEAR AGO
Source text for Eikon: ID:nWkr3WyrsQ
Further company coverage: 9F1.F
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))